ARCHIVES

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

This article is from The Cancer Letter archive.

Vol. 25 No. 41 | October 29, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

NCI’s Kramer Named Director, NIH Medical Applications Office.

June 16, 2000

Lippman Named UCSD Cancer Center Director

May 4, 2012

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins

January 9, 1987